3 unknown. 3 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 3 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow FB2001: new trials by email Literature Review of FB2001 trials Research Report on FB2001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19 FB2001, FB2001 placebo - Mild to Moderate COVID-19 | Phase 2 / Phase 3 | Unknown | Frontier Biotechnologies Inc. | 1336 | 2023-01-04 | 2023-01-09 |
| Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study) FB2001, FB2001 placebo - COVID-19 | Phase 2 / Phase 3 | Unknown | Frontier Biotechnologies Inc. | 1188 | 2022-09-14 | 2023-01-05 |
| Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts FB2001 - Close Contact Transmission | Phase 1 / Phase 2 | Unknown | Ruijin Hospital | 60 | 2022-06-09 | 2022-06-13 |
COVID-19 (1) · Coronavirus Infections (1)
Frontier Biotechnologies Inc. (2) · Ruijin Hospital (1)
China (2)
Cheng Yao (2)